Cost-effectiveness analysis of oral paracetamol and ibuprofen for treating pain after soft tissue limb injuries: double-blind, randomised controlled trial
ISRCTN | ISRCTN94738550 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN94738550 |
ClinicalTrials.gov number | NCT00528658 |
Secondary identifying numbers | HKCEM06-07/DG2041095 |
- Submission date
- 06/09/2007
- Registration date
- 19/10/2007
- Last edited
- 15/07/2021
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Injury, Occupational Diseases, Poisoning
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English Summary
Not provided at time of registration
Contact information
Prof Colin Graham
Scientific
Scientific
Trauma and Emergency Centre
Prince of Wales Hospital
Shatin
NT
Hong Kong
Study information
Study design | Prospective, double-blind, randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Scientific title | Cost-effectiveness analysis of oral paracetamol and ibuprofen for treating pain after soft tissue limb injuries: double-blind, randomised controlled trial |
Study hypothesis | We hypothesise firstly that paracetamol 1 g and ibuprofen 400 mg administered orally for soft tissue injuries have equal analgesic efficacy; secondly that paracetamol has less adverse effects than ibuprofen; and that when all additional health care related costs are taken into account, that paracetamol will be the more cost-effective option. |
Ethics approval(s) | Ethics approval received from the Joint Chinese University of Hong Kong - New Territories East Cluster (CUHK-NTEC) Clinical Research Ethics Committee on the 8th October 2004 (ref: CRE-2004.266-T). |
Condition | Soft Tissue Injuries |
Intervention | Arm 1: Paracetamol 1 g four times daily (qid) and ibuprofen placebo equivalent to 400 mg three times daily (tid) Arm 2: Paracetamol placebo equivalent to 1 g qid and ibuprofen 400 mg tid Arm 3: Paracetamol 1 g qid and ibuprofen 400 mg tid Treatment will continue for three days, follow-up will continue for 30 days. |
Intervention type | Drug |
Pharmaceutical study type(s) | |
Phase | Not Specified |
Drug / device / biological / vaccine name(s) | Paracetamol, ibuprofen |
Primary outcome measure | Analgesic efficacy both at rest and with movement at 72 hours. |
Secondary outcome measures | 1. Presence, frequency and duration of adverse effects at 30 days 2. Cost-effectiveness analysis at 30 days 3. Patient satisfaction with analgesia at 30 days |
Overall study start date | 01/01/2005 |
Overall study end date | 31/12/2007 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Sex | Both |
Target number of participants | 783 |
Total final enrolment | 782 |
Participant inclusion criteria | All patients greater than 16 years presenting to the Emergency Department (ED) with isolated soft tissue injury without significant fracture between 9 am to 5 pm, Monday to Friday. |
Participant exclusion criteria | Patients will be excluded if there is: 1. A history of peptic ulceration or haemorrhage 2. Recent anticoagulation 3. Pregnancy 4. Adverse reaction to paracetamol or ibuprofen 5. Renal or cardiac failure 6. Hepatic problems 7. Rectal bleeding 8. Chronic Non-Steriodal Anti-Inflammatory Drug (NSAID) consumption 9. Asthma 10. Chronic obstructive pulmonary disease 11. Chronic pain syndromes 12. Prior treatment with analgesia for the same injury Patients will also be excluded if they have a physical, visual or cognitive impairment making use of the visual analogue scale unreliable. |
Recruitment start date | 01/01/2005 |
Recruitment end date | 31/12/2007 |
Locations
Countries of recruitment
- Hong Kong
Study participating centre
Trauma and Emergency Centre
Shatin
NT
Hong Kong
NT
Hong Kong
Sponsor information
Chinese University of Hong Kong (Hong Kong)
University/education
University/education
Trauma and Emergency Centre
Prince of Wales Hospital
Shatin
NT
Hong Kong
Website | http://www.cuhk.edu.hk |
---|---|
https://ror.org/00t33hh48 |
Funders
Funder type
University/education
Chinese University of Hong Kong (Hong Kong) (Direct Grant: 2041095)
No information available
Hong Kong College of Emergency Medicine (Hong Kong) (Grant: 2006-07)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | 06/02/2018 | 15/07/2021 | Yes | No |
Editorial Notes
15/07/2021: ClinicalTrials.gov number, total final enrolment and publication reference added.